Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyMolecularFunction(R)-limonene 6-monooxygenase activity

CYP2C19 CYP2C9

4.54e-0521352GO:0052741
GeneOntologyMolecularFunction(S)-limonene 6-monooxygenase activity

CYP2C19 CYP2C9

4.54e-0521352GO:0018675
GeneOntologyMolecularFunction(S)-limonene 7-monooxygenase activity

CYP2C19 CYP2C9

4.54e-0521352GO:0018676
GeneOntologyMolecularFunctionlimonene monooxygenase activity

CYP2C19 CYP2C9

4.54e-0521352GO:0019113
GeneOntologyMolecularFunctionRNA polymerase II sequence-specific DNA-binding transcription factor recruiting activity

NANOGP8 NANOG

2.70e-0441352GO:0001010
GeneOntologyMolecularFunctionarachidonate 11,12-epoxygenase activity

CYP2C19 CYP2C9

2.70e-0441352GO:0008405
GeneOntologyMolecularFunctionlinoleic acid epoxygenase activity

CYP2C19 CYP2C9

2.70e-0441352GO:0071614
GeneOntologyMolecularFunctionfatty acid omega-1 hydroxylase activity

CYP2C19 CYP2C9

4.48e-0451352GO:0120502
GeneOntologyMolecularFunctionlong-chain fatty acid omega-1 hydroxylase activity

CYP2C19 CYP2C9

4.48e-0451352GO:0120319
GeneOntologyMolecularFunctionarachidonate 14,15-epoxygenase activity

CYP2C19 CYP2C9

4.48e-0451352GO:0008404
GeneOntologyMolecularFunctionlysine-acetylated histone binding

NANOGP8 NANOG BRD4

1.07e-03301353GO:0070577
GeneOntologyMolecularFunctionacetylation-dependent protein binding

NANOGP8 NANOG BRD4

1.18e-03311353GO:0140033
GeneOntologyMolecularFunctionoxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor

CYP2C19 CYP2C9

1.24e-0381352GO:0033695
GeneOntologyMolecularFunctioncaffeine oxidase activity

CYP2C19 CYP2C9

1.24e-0381352GO:0034875
GeneOntologyMolecularFunctionDNA-binding transcription activator activity, RNA polymerase II-specific

NANOGP8 HIVEP2 NANOG POU1F1 GCM1 HOXB1 HOXD8 NFATC1 NR2E1 PAX1 MYBL1

1.49e-0356013511GO:0001228
GeneOntologyMolecularFunctionDNA-binding transcription activator activity

NANOGP8 HIVEP2 NANOG POU1F1 GCM1 HOXB1 HOXD8 NFATC1 NR2E1 PAX1 MYBL1

1.62e-0356613511GO:0001216
DomainCUB

TMPRSS6 CUBN CSMD2 CSMD3 SEZ6L2 NRP2 LRP3 CSMD1

2.37e-09501348SM00042
Domain-

TMPRSS6 CUBN CSMD2 CSMD3 SEZ6L2 NRP2 LRP3 CSMD1

3.28e-095213482.60.120.290
DomainCUB

TMPRSS6 CUBN CSMD2 CSMD3 SEZ6L2 NRP2 LRP3 CSMD1

3.84e-09531348PS01180
DomainCUB_dom

TMPRSS6 CUBN CSMD2 CSMD3 SEZ6L2 NRP2 LRP3 CSMD1

6.99e-09571348IPR000859
DomainCUB

CUBN CSMD2 CSMD3 SEZ6L2 NRP2 LRP3 CSMD1

5.59e-08491347PF00431
DomainLDrepeatLR_classA_rpt

TMPRSS6 LRP3 CORIN PRKCSH C8B

2.61e-05491345IPR002172
DomainLDLa

TMPRSS6 LRP3 CORIN PRKCSH C8B

2.61e-05491345SM00192
DomainSushi

CSMD2 CSMD3 SEZ6L2 SVEP1 CSMD1

3.50e-05521345PF00084
DomainCCP

CSMD2 CSMD3 SEZ6L2 SVEP1 CSMD1

4.21e-05541345SM00032
DomainSUSHI

CSMD2 CSMD3 SEZ6L2 SVEP1 CSMD1

5.02e-05561345PS50923
DomainARHGEF5_35

ARHGEF5 ARHGEF35

5.11e-0521342PF15441
DomainARHGEF5/35_N

ARHGEF5 ARHGEF35

5.11e-0521342IPR029212
DomainSushi_SCR_CCP_dom

CSMD2 CSMD3 SEZ6L2 SVEP1 CSMD1

5.47e-05571345IPR000436
DomainLdl_recept_a

TMPRSS6 LRP3 CORIN C8B

3.00e-04451344PF00057
Domain-

TMPRSS6 LRP3 CORIN PRKCSH

3.27e-044613444.10.400.10
DomainLDLRA_1

TMPRSS6 LRP3 CORIN C8B

3.86e-04481344PS01209
DomainLDLRA_2

TMPRSS6 LRP3 CORIN C8B

4.18e-04491344PS50068
DomainHomeodomain-like

NANOGP8 MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8 PAX1 MYBL1

6.63e-043321349IPR009057
DomainA1B_glyco/leuk_Ig-like_rcpt

A1BG LILRA6

7.52e-0461342IPR016332
DomainhEGF

SVEP1 EYS FBN3

1.04e-03281343PF12661
DomainSec1-like

STXBP2 VPS33B

1.39e-0381342IPR001619
DomainSec-1-like_dom2

STXBP2 VPS33B

1.39e-0381342IPR027482
DomainSec1

STXBP2 VPS33B

1.39e-0381342PF00995
Domain-

STXBP2 VPS33B

1.39e-03813423.40.50.1910
DomainHomeobox

NANOGP8 MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8

1.51e-032341347PF00046
DomainHOMEOBOX_1

NANOGP8 MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8

1.59e-032361347PS00027
DomainHOX

NANOGP8 MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8

1.63e-032371347SM00389
DomainHOMEOBOX_2

NANOGP8 MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8

1.71e-032391347PS50071
DomainHomeobox_dom

NANOGP8 MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8

1.71e-032391347IPR001356
DomainCopine

CPNE2 CPNE7

1.78e-0391342PF07002
DomainCopine

CPNE2 CPNE7

1.78e-0391342IPR010734
DomainHomeobox_CS

MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8

2.25e-031861346IPR017970
DomainEphrin_rec_like

SVEP1 TG

2.69e-03111342PF07699
DomainLDLR_class-A_CS

LRP3 CORIN C8B

2.94e-03401343IPR023415
Domain-

FCF1 MARF1

3.22e-031213423.40.50.1010
DomainC8

FCGBP MUC2

3.22e-03121342PF08742
DomainTIL

FCGBP MUC2

3.22e-03121342PF01826
DomainUnchr_dom_Cys-rich

FCGBP MUC2

3.78e-03131342IPR014853
DomainC8

FCGBP MUC2

3.78e-03131342SM00832
DomainHomeobox_metazoa

MNX1 MSX2 HOXB1 HOXD8

4.02e-03901344IPR020479
DomainCyt_P450_E_grp-I

CYP2C19 CYP2C9 CYP4X1

4.11e-03451343IPR002401
Domain-

MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8 MYBL1

4.36e-0328313471.10.10.60
DomainTIL_dom

FCGBP MUC2

4.39e-03141342IPR002919
DomainPIN_domain-like

FCF1 MARF1

4.39e-03141342IPR029060
DomainN2O_reductase_N

PEX7 EML1

5.05e-03151342IPR011045
DomainEGF_Ca-bd_CS

CUBN SVEP1 EYS FBN3

5.25e-03971344IPR018097
DomainEGF_CA

CUBN SVEP1 EYS FBN3

5.64e-03991344PS01187
DomainVWF_A

CPNE2 SEC24A SVEP1 CPNE7

5.64e-03991344IPR002035
DomainVWF_type-D

FCGBP MUC2

5.74e-03161342IPR001846
DomainVWFD

FCGBP MUC2

5.74e-03161342PS51233
DomainVWD

FCGBP MUC2

5.74e-03161342SM00216
DomainVWD

FCGBP MUC2

5.74e-03161342PF00094
DomainASX_HYDROXYL

CUBN SVEP1 EYS FBN3

5.84e-031001344PS00010
DomainCyt_P450_CS

CYP2C19 CYP2C9 CYP4X1

6.51e-03531343IPR017972
DomainEGF

HYAL4 CUBN SVEP1 EYS FCGBP FBN3

7.03e-032351346SM00181
DomainEGF-type_Asp/Asn_hydroxyl_site

CUBN SVEP1 EYS FBN3

7.16e-031061344IPR000152
Pubmed

Identification of two new members of the CSMD gene family.

CSMD2 CSMD3 CSMD1

6.38e-083140312906867
Pubmed

BRD4 regulates Nanog expression in mouse embryonic stem cells and preimplantation embryos.

NANOGP8 NANOG BRD4

2.55e-074140325146928
Pubmed

Porcn-dependent Wnt signaling is not required prior to mouse gastrulation.

NANOGP8 NANOG HOXB1 BMP4

1.16e-0620140423760955
Pubmed

Screening large numbers of expression patterns of transcription factors in late stages of the mouse thymus.

NANOGP8 MNX1 NANOG POU1F1 MSX2 HOXB1 HOXD8 LPXN NR2E1

1.30e-06263140920932939
Pubmed

Influence of FGF4 and BMP4 on FGFR2 dynamics during the segregation of epiblast and primitive endoderm cells in the pre-implantation mouse embryo.

NANOGP8 NANOG BMP4

2.21e-067140337471320
Pubmed

Genetic mapping of the murine gene and 14 related sequences encoding chromosomal protein HMG-14.

CYP2C19 CYP2C9 POU1F1 MPI

2.51e-062414041360278
Pubmed

Genome-wide association study of lung function decline in adults with and without asthma.

SVEP1 FLRT2 CTNND2 CSMD1

8.29e-0632140422424883
Pubmed

Fully functional hair follicle regeneration through the rearrangement of stem cells and their niches.

ITGA6 MSX2 BMP4

1.03e-0511140322510689
Pubmed

Dynamic expression of Lrp2 pathway members reveals progressive epithelial differentiation of primitive endoderm in mouse blastocyst.

NANOGP8 NANOG CUBN

1.03e-0511140318083160
Pubmed

The BMP antagonist Noggin promotes cranial and spinal neurulation by distinct mechanisms.

MSX2 BMP4 PAX1

1.03e-0511140316712836
Pubmed

Msx1 deficiency interacts with hypoxia and induces a morphogenetic regulation during mouse lip development.

MSX2 BMP4 PAX1

1.03e-0511140332467233
Pubmed

Differential expression of Sonic hedgehog along the anterior-posterior axis regulates patterning of pharyngeal pouch endoderm and pharyngeal endoderm-derived organs.

HOXB1 BMP4 PAX1

1.37e-0512140315680353
Pubmed

Important amino acid residues that confer CYP2C19 selective activity to CYP2C9.

CYP2C19 CYP2C9

1.61e-052140218511451
Pubmed

Developmental expression of human hepatic CYP2C9 and CYP2C19.

CYP2C19 CYP2C9

1.61e-052140214634042
Pubmed

CYP2C40, a unique arachidonic acid 16-hydroxylase, is the major CYP2C in murine intestinal tract.

CYP2C19 CYP2C9

1.61e-052140210908295
Pubmed

Oxygenation mechanism in conversion of aldehyde to carboxylic acid catalyzed by a cytochrome P-450 isozyme.

CYP2C19 CYP2C9

1.61e-05214021847130
Pubmed

Cytochromes P450 catalyze oxidation of alpha,beta-unsaturated aldehydes.

CYP2C19 CYP2C9

1.61e-052140217599801
Pubmed

Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms.

CYP2C19 CYP2C9

1.61e-052140215385837
Pubmed

[Effect of original and generic clopidogrel on prognosis in relation to different gene polymorphisms].

CYP2C19 CYP2C9

1.61e-052140225518510
Pubmed

Chlorpropamide 2-hydroxylation is catalysed by CYP2C9 and CYP2C19 in vitro: chlorpropamide disposition is influenced by CYP2C9, but not by CYP2C19 genetic polymorphism.

CYP2C19 CYP2C9

1.61e-052140215842554
Pubmed

Rapid identification of the hepatic cytochrome P450 2C19 activity using a novel and noninvasive [13C]pantoprazole breath test.

CYP2C19 CYP2C9

1.61e-052140219136640
Pubmed

Mouse Cyp2c expression and zonation structure in the liver begins in the early neonatal stage.

CYP2C19 CYP2C9

1.61e-052140235748067
Pubmed

Time serial transcriptome reveals Cyp2c29 as a key gene in hepatocellular carcinoma development.

CYP2C19 CYP2C9

1.61e-052140232587777
Pubmed

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Iranian population.

CYP2C19 CYP2C9

1.61e-052140217201743
Pubmed

CYP2C9 (*2&*3) and CYP2C19 (*2&*3) polymorphisms among children with nonlesional epilepsy: a single-center study.

CYP2C19 CYP2C9

1.61e-052140232683556
Pubmed

Evaluation of phenytoin dosage regimens based on genotyping of CYP2C subfamily in routinely treated Japanese patients.

CYP2C19 CYP2C9

1.61e-052140215855721
Pubmed

Functional evidence that the self-renewal gene NANOG regulates human tumor development.

NANOGP8 NANOG

1.61e-052140219415763
Pubmed

The effects of CYP2C9 and CYP2C19 genetic polymorphisms on the pharmacokinetics and pharmacodynamics of glipizide in Chinese subjects.

CYP2C19 CYP2C9

1.61e-052140219847408
Pubmed

CYP2C9 and CYP2C19 polymorphic forms are related to increased indisulam exposure and higher risk of severe hematologic toxicity.

CYP2C19 CYP2C9

1.61e-052140217504998
Pubmed

Cytochrome P450 2C epoxygenases mediate photochemical stress-induced death of photoreceptors.

CYP2C19 CYP2C9

1.61e-052140224519941
Pubmed

Mouse liver CYP2C39 is a novel retinoic acid 4-hydroxylase. Its down-regulation offers a molecular basis for liver retinoid accumulation and fibrosis in aryl hydrocarbon receptor-null mice.

CYP2C19 CYP2C9

1.61e-052140214623888
Pubmed

The IgGFc-binding protein FCGBP is secreted with all GDPH sequences cleaved but maintained by interfragment disulfide bonds.

FCGBP MUC2

1.61e-052140234126068
Pubmed

Rapid testing of clopidogrel resistance by genotyping of CYP2C19 and CYP2C9 polymorphisms using denaturing on-chip capillary electrophoresis.

CYP2C19 CYP2C9

1.61e-052140222589111
Pubmed

CYP2C9 and CYP2C19 genetic polymorphisms: frequencies in the south Indian population.

CYP2C19 CYP2C9

1.61e-052140215660966
Pubmed

FGF2 sustains NANOG and switches the outcome of BMP4-induced human embryonic stem cell differentiation.

NANOG BMP4

1.61e-052140221362572
Pubmed

Association of galactose single-point test levels and phenytoin metabolic polymorphisms with gingival hyperplasia in patients receiving long-term phenytoin therapy.

CYP2C19 CYP2C9

1.61e-052140218154472
Pubmed

Impact of age, gender and CYP2C9/2C19 genotypes on dose-adjusted steady-state serum concentrations of valproic acid-a large-scale study based on naturalistic therapeutic drug monitoring data.

CYP2C19 CYP2C9

1.61e-052140227353638
Pubmed

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics of gliclazide MR in Chinese subjects.

CYP2C19 CYP2C9

1.61e-052140217298483
Pubmed

Analysis of the Potential Association of Drug-Metabolizing Enzymes CYP2C9*3 and CYP2C19*3 Gene Variations With Type 2 Diabetes: A Case-Control Study.

CYP2C19 CYP2C9

1.61e-052140233115391
Pubmed

Loss of CSMD1 or 2 may contribute to the poor prognosis of colorectal cancer patients.

CSMD2 CSMD1

1.61e-052140224408017
Pubmed

Contributions of CYP2C9/CYP2C19 genotypes and drug interaction to the phenytoin treatment in the Korean epileptic patients in the clinical setting.

CYP2C19 CYP2C9

1.61e-052140217562299
Pubmed

Prevalence of CYP2C9 and CYP2C19 variants and the impact on clopidogrel efficacy in patients having CYPC19*2 variant.

CYP2C19 CYP2C9

1.61e-052140236960518
Pubmed

Paxillin phosphorylation by JNK and p38 is required for NFAT activation.

NFATC1 PXN

1.61e-052140222865050
Pubmed

Characterization of drug-metabolizing enzymes CYP2C9, CYP2C19 polymorphisms in Tunisian, Kuwaiti and Bahraini populations.

CYP2C19 CYP2C9

1.61e-052140226690534
Pubmed

Covariate-based dose individualization of the cytotoxic drug indisulam to reduce the risk of severe myelosuppression.

CYP2C19 CYP2C9

1.61e-052140219199010
Pubmed

A comparative analysis of binding sites between mouse CYP2C38 and CYP2C39 based on homology modeling, molecular dynamics simulation and docking studies.

CYP2C19 CYP2C9

1.61e-052140219358898
Pubmed

Cyp2c-deficiency depletes muricholic acids and protects against high-fat diet-induced obesity in male mice but promotes liver damage.

CYP2C19 CYP2C9

1.61e-052140234438105
Pubmed

Chromosomal organization of the cytochrome P450-2C gene family in the mouse: a locus associated with constitutive aryl hydrocarbon hydroxylase.

CYP2C19 CYP2C9

1.61e-05214022895926
Pubmed

Associations between single nucleotide polymorphisms in iron-related genes and iron status in multiethnic populations.

TMPRSS6 CUBN

1.61e-052140222761678
Pubmed

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on pharmacokinetics and pharmacodynamics of gliclazide in healthy Chinese Han volunteers.

CYP2C19 CYP2C9

1.61e-052140220831536
Pubmed

Signalling between the hindbrain and paraxial tissues dictates neural crest migration pathways.

MSX2 BMP4

1.61e-052140211807035
Pubmed

CYP2C9, but not CYP2C19, polymorphisms affect the pharmacokinetics and pharmacodynamics of glyburide in Chinese subjects.

CYP2C19 CYP2C9

1.61e-052140216198656
Pubmed

[Association between genetic polymorphisms of CYP2C19 and CYP2C9 and phenytoin serum concentration].

CYP2C19 CYP2C9

1.61e-052140215569425
Pubmed

An association between the rs1799853 and rs1057910 polymorphisms of CYP2C9, the rs4244285 polymorphism of CYP2C19 and the prevalence rates of drug-resistant epilepsy in children.

CYP2C19 CYP2C9

1.61e-052140232567426
Pubmed

Role of CYP2C9 and CYP2C19 polymorphisms in patients with atherosclerosis.

CYP2C19 CYP2C9

1.61e-052140217868191
Pubmed

Impact of CYP2C19 and CYP2C9 gene polymorphisms on sodium valproate plasma concentration in patients with epilepsy.

CYP2C19 CYP2C9

1.61e-052140232868386
Pubmed

Proteomic analyses of the two mucus layers of the colon barrier reveal that their main component, the Muc2 mucin, is strongly bound to the Fcgbp protein.

FCGBP MUC2

1.61e-052140219432394
Pubmed

CYP2C9 and CYP2C19 Allele and Haplotype Distributions in Four Mestizo Populations from Western Mexico: An Interethnic Comparative Study.

CYP2C19 CYP2C9

1.61e-052140227617498
Pubmed

Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India.

CYP2C19 CYP2C9

1.61e-052140216873909
Pubmed

Comparison of the in vitro mutagenicity and metabolism of dimethylnitrosamine and benzo[a]pyrene in tissues from inbred mice treated with phenobarbital, 3-methylcholanthrene or polychlorinated biphenyls.

CYP2C19 CYP2C9

1.61e-0521402106274
Pubmed

Genetic polymorphism of CYP2C9 and CYP2C19 in a Bolivian population: an investigative and comparative study.

CYP2C19 CYP2C9

1.61e-052140215776277
Pubmed

Effect of cytochrome P450 2C19 and 2C9 amino acid residues 72 and 241 on metabolism of tricyclic antidepressant drugs.

CYP2C19 CYP2C9

1.61e-052140224492587
Pubmed

Phase I pharmacokinetic and pharmacogenomic study of E7070 administered once every 21 days.

CYP2C19 CYP2C9

1.61e-052140216232205
Pubmed

Genetic polymorphisms of cytochrome P450 enzymes 2C9 and 2C19 in a healthy Mongolian population in China.

CYP2C19 CYP2C9

1.61e-052140220845310
Pubmed

Cloning and expression of murine CYP2Cs and their ability to metabolize arachidonic acid.

CYP2C19 CYP2C9

1.61e-05214029721182
Pubmed

Cytochrome P450 polymorphisms in patients with Behcet's disease.

CYP2C19 CYP2C9

1.61e-052140217269966
Pubmed

Nanog1 in NTERA-2 and recombinant NanogP8 from somatic cancer cells adopt multiple protein conformations and migrate at multiple M.W species.

NANOGP8 NANOG

1.61e-052140224598770
Pubmed

A genetic association study of CSMD1 and CSMD2 with cognitive function.

CSMD2 CSMD1

1.61e-052140227890662
Pubmed

Metabolism of (+)- and (-)-limonenes to respective carveols and perillyl alcohols by CYP2C9 and CYP2C19 in human liver microsomes.

CYP2C19 CYP2C9

1.61e-052140211950794
Pubmed

Differential expression of nanog1 and nanogp8 in colon cancer cells.

NANOGP8 NANOG

1.61e-052140222079639
Pubmed

Genetic polymorphisms of CYP2C9 and CYP2C19 are not related to drug-induced idiosyncratic liver injury (DILI).

CYP2C19 CYP2C9

1.61e-052140217279092
Pubmed

Associations of CYP2C9 and CYP2C19 Pharmacogenetic Variation with Phenytoin-Induced Cutaneous Adverse Drug Reactions.

CYP2C19 CYP2C9

1.61e-052140232216088
Pubmed

cDNA cloning and sequence of CYP2C29 encoding P-450 MUT-2, a microsomal aldehyde oxygenase.

CYP2C19 CYP2C9

1.61e-05214028130255
Pubmed

Membrane integration of recombinant human P450 forms.

CYP2C19 CYP2C9

1.61e-052140219534586
Pubmed

The complement control-related genes CSMD1 and CSMD2 associate to schizophrenia.

CSMD2 CSMD1

1.61e-052140221439553
Pubmed

The homeobox transcription factor MSX2 partially mediates the effects of bone morphogenetic protein 4 (BMP4) on somatic cell reprogramming.

MSX2 BMP4

1.61e-052140230097516
Pubmed

Inter-phenotypic differences in CYP2C9 and CYP2C19 metabolism: Bayesian meta-regression of human population variability in kinetics and application in chemical risk assessment.

CYP2C19 CYP2C9

1.61e-052140233232775
Pubmed

Population estimation of the effects of cytochrome P450 2C9 and 2C19 polymorphisms on phenobarbital clearance in Japanese.

CYP2C19 CYP2C9

1.61e-052140217304159
Pubmed

Genetic Polymorphisms of CYP2C9/CYP2C19 in Chronic Obstructive Pulmonary Disease.

CYP2C19 CYP2C9

1.61e-052140232757668
Pubmed

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on phenytoin-induced neurological toxicity in Indian epileptic patients.

CYP2C19 CYP2C9

1.61e-052140220390258
Pubmed

Effects of genetic variation at the CYP2C19/CYP2C9 locus on pharmacokinetics of chlorcycloguanil in adult Gambians.

CYP2C19 CYP2C9

1.61e-052140219761366
Pubmed

Genetic polymorphisms of CYP2C9 and CYP2C19 in the Beninese and Belgian populations.

CYP2C19 CYP2C9

1.61e-052140214616425
Pubmed

Influence of CYP2C9 and CYP2C19 genetic polymorphisms on warfarin maintenance dose and metabolic clearance.

CYP2C19 CYP2C9

1.61e-052140212496751
Pubmed

Voriconazole metabolism, toxicity, and the effect of cytochrome P450 2C19 genotype.

CYP2C19 CYP2C9

1.61e-052140224403552
Pubmed

Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells.

NANOGP8 NANOG

1.61e-052140221136380
Pubmed

Paxillin controls endothelial cell migration and tumor angiogenesis by altering neuropilin 2 expression.

NRP2 PXN

1.61e-052140224522185
Pubmed

BET proteins are essential for the specification and maintenance of the epiblast lineage in mouse preimplantation embryos.

NANOGP8 NANOG BRD4

1.77e-0513140335264162
Pubmed

Altered subcellular localization of transcription factor TEAD4 regulates first mammalian cell lineage commitment.

NANOGP8 NANOG BMP4

1.77e-0513140322529382
Pubmed

Smad4 is essential for epiblast scaling and morphogenesis after implantation, but nonessential before implantation.

NANOGP8 NANOG BMP4

1.77e-0513140338752427
Pubmed

Ino80 is essential for proximal-distal axis asymmetry in part by regulating Bmp4 expression.

NANOGP8 NANOG BMP4

2.25e-0514140326975355
Pubmed

Stabilization of beta-catenin in the mouse zygote leads to premature epithelial-mesenchymal transition in the epiblast.

NANOGP8 NANOG BMP4

2.25e-0514140315525667
Pubmed

Distinct Requirements for FGFR1 and FGFR2 in Primitive Endoderm Development and Exit from Pluripotency.

NANOGP8 NANOG GCM1

2.25e-0514140328552557
Pubmed

Mesodermal defects and cranial neural crest apoptosis in alpha5 integrin-null embryos.

HOXB1 BMP4 PAX1

2.80e-051514039334279
Pubmed

Mouse models of ocular diseases.

BMP4 CRYGD NR2E1 ADAM17

3.01e-0544140416332269
Pubmed

Pluripotency factors regulate definitive endoderm specification through eomesodermin.

NANOGP8 NANOG HOXB1

3.44e-0516140321245162
Pubmed

Vertebrate homeobox gene nomenclature.

MSX2 HOXB1 HOXD8 NR2E1

3.92e-054714041358459
Pubmed

Sall4 is essential for mouse primordial germ cell specification by suppressing somatic cell program genes.

NANOGP8 NANOG HOXB1

4.17e-0517140325263278
Pubmed

Msx1 and Msx2 are required for endothelial-mesenchymal transformation of the atrioventricular cushions and patterning of the atrioventricular myocardium.

MSX2 BMP4 NFATC1

4.17e-0517140318667074
Pubmed

SOX3 activity during pharyngeal segmentation is required for craniofacial morphogenesis.

HOXB1 BMP4 PAX1

4.17e-0517140317728342
Pubmed

Combined deficiencies of Msx1 and Msx2 cause impaired patterning and survival of the cranial neural crest.

MSX2 HOXB1 BMP4

4.17e-0517140316221730
GeneFamilyHyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing

CSMD2 CSMD3 SEZ6L2 SVEP1 CSMD1

1.22e-05579551179
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

SFPQ CNST MARF1 PLCL1 CSMD1 TNS1

3.85e-04181956694
GeneFamilyCopines

CPNE2 CPNE7

9.60e-049952829
GeneFamilyHOXL subclass homeoboxes

MNX1 HOXB1 HOXD8

2.58e-0352953518
GeneFamilyAAA ATPases|Peroxins

PEX7 PEX12

3.12e-0316952957
ToppCellfacs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP2 TMPRSS6 CUBN CSMD3 CNTN6 OTOGL DNAH11

1.10e-06169140712bdc709bc000d7f9061ecd9fbd57233eaacb7e2
ToppCellSmart-seq2-blood_(Smart-seq2)-myeloid-myeloid_monocytic-classical_monocyte|blood_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CSMD3 KIF24 OTOGL C18orf63 ADAMTS20 FLRT2 CSMD1

2.08e-06186140723b8d51d20b05795a73892d3e20e0f9b6a207820
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

NTMT2 CNTN6 ADAMTS20 CORIN PAX1 MMD

2.12e-061191406d8fbea9ded96fcc3ebdfb4d28873c563427ce811
ToppCellTCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Desmoid_Tumor-7|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9

NTMT2 CNTN6 ADAMTS20 CORIN PAX1 MMD

2.12e-0611914069e38f13bf98b9ee44b178300e6f80fd08a006296
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

STAC3 RHBDD2 ABCG1 STXBP2 LPXN C8B MMD

2.95e-061961407eb7d6bbfb766cdeaf5fe0f0bb66a5f491fd5ef26
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 CSMD3 CDH20 NR2E1 PLCL1 CPNE7

3.09e-061271406f808c727c0817ed10e76eaffa9493a516e9a6b50
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1|Neuronal / cells hierarchy compared to all cells using T-Statistic

CPNE2 SVEP1 CNTN6 NEK3 NR2E1 FBN3 CPNE7

3.37e-062001407dd68ce6934eafb75d918042fcf7fd7a750294b7f
ToppCellNeuronal-Inhibitory-iA-iA_3(VIP)-VIP_3-HS3ST3A1-L3-6|Neuronal / cells hierarchy compared to all cells using T-Statistic

CPNE2 SVEP1 CNTN6 NEK3 NR2E1 FBN3 CPNE7

3.37e-06200140706ea96428728199a30a0f836647d6448287d3848
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 ADCY2 CDH20 NR2E1 PLCL1 CPNE7

5.21e-0613914069e9f29f92dbe65b26cc78b3a1c00778c6a701f5b
ToppCellCOVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type

CSMD2 CSMD3 ADCY2 EYS CTNND2 CSMD1

1.13e-0515914065335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 NFATC1 FLRT2 DUOXA2

1.25e-05162140696c6e94a10b124a1d25dcd705ec5aaa8609c1089
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CUBN CSMD2 CSMD3 EYS CTNND2 CSMD1

1.49e-0516714063edb0570e583bb527165bcd8a4c25a042054043b
ToppCell3'-Broncho-tracheal-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

STAC3 RHBDD2 ABCG1 RNPEP ADAM17 C8B

2.13e-0517814060b398656f26c4061b11ccf98908d0e2e1367585a
ToppCellLPS_only-Lymphocytic_NKT-T_cells-T-cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITGA6 ABCG1 NFATC1 LPXN PLCL1 MMD

2.27e-051801406dcef253f2e97e4436b1b04e8a06a53ff6e64522c
ToppCellLPS_only-Lymphocytic_NKT-T_cells|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ITGA6 ABCG1 NFATC1 LPXN PLCL1 MMD

2.34e-051811406a4347ae554e6dcf03c7001a2b69332b377c7c034
ToppCellE18.5-samps-Mesenchymal-Matrix_fibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass

SFPQ GCM1 CPED1 SVEP1 HOXB1 TNS1

2.42e-051821406ceb37c214662a48efb56ab0d015977c6fab478b0
ToppCelltumor_Lymph_Node_/_Brain-Myeloid_cells-Alveolar_Mac|Myeloid_cells / Location, Cell class and cell subclass

RHBDD2 ADCY2 ABCG1 STXBP2 CORIN C8B

2.42e-051821406a035d45fd512bee8dac38eb387dbf39f5a8a1fed
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFCAB6 CSMD3 OTOGL ADAMTS20 CSMD1 DNAH11

2.57e-0518414062cbed6462fea2622871bb7e49b0df3d984239281
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFCAB6 CSMD3 OTOGL ADAMTS20 CSMD1 DNAH11

2.57e-051841406ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCellfacs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

EFCAB6 CSMD3 OTOGL ADAMTS20 CSMD1 DNAH11

2.57e-0518414062b19a8c5f823e00812908b23e66bb4e563278aff
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CPNE2 SEZ6L2 SVEP1 CNTN6 NR2E1 FBN3

2.90e-0518814066ee3f8f94ea7bdf652c9575fc65bff08070093a4
ToppCellpdx-Tumor_cells-T8|Tumor_cells / Sample and Cell Type and Tumor Cluster (all cells)

A1BG NDST1 TMPRSS6 UROC1 NAALADL2 TNS1

3.08e-051901406b05db0de9b6ae01dd30074453f7de44f7397631e
ToppCellwk_20-22-Endothelial-Lymph_endothelial|wk_20-22 / Celltypes from embryonic and fetal-stage human lung

ITGA6 MSMP NRP2 HOXD8 NFATC1 FLRT2

3.17e-051911406631f95fd80dd3678b5b2ef201abf7fe646049af6
ToppCell356C-Epithelial_cells-Epithelial-I_(AT1)|356C / Donor, Lineage, Cell class and subclass (all cells)

NDST1 KLK10 CNTN6 CTNND2 TNS1 FBN3

3.56e-05195140607a3ef6b0f1201fe2bcb9ea426b8f7a69beb4904
ToppCell356C-Epithelial_cells-Epithelial-I_(AT1)-|356C / Donor, Lineage, Cell class and subclass (all cells)

NDST1 KLK10 CNTN6 CTNND2 TNS1 FBN3

3.56e-051951406b65511770ed67f7447847e2187555b362988af45
ToppCellBAL-Control-cDC_10|Control / Compartment, Disease Groups and Clusters

LYST NRP2 ST3GAL5 PLCL1 MMD DNAH11

3.66e-051961406c32b7b7e6a4781c19c30c6e32d5563f82355deb0
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

LILRA6 TMEM38B FCF1 STXBP2 LPXN ADAM17

3.66e-051961406a7291291931f9e5abd6a54349bc920a0ab68a4cb
ToppCell3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.0.4.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

STAC3 RHBDD2 ABCG1 STXBP2 LPXN C8B

3.76e-0519714064f022bae7af2ca23689cc0d35046a7e23dba6e9c
ToppCell(2)_NK/T-(22)_CD8+_T_cell|(2)_NK/T / immune cells in Peripheral Blood (logTPM normalization)

A1BG CPNE2 MAPKAPK2 COLQ MYBL1 CPNE7

3.76e-05197140620dad8e4ed36a0185e231ddcb327725d2b2005e0
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPEG CPED1 NRP2 OTOGL TNS1 DNAH11

3.76e-051971406ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPEG CPED1 NRP2 PLCL1 TNS1 DNAH11

3.87e-051981406c12e7511628db819a52959bb68580e27c00c2e41
ToppCellTracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

SPEG CPED1 NRP2 PLCL1 TNS1 DNAH11

3.87e-05198140622e766df1276c5b14aa0d83f434f47140ebb98ea
ToppCellBAL-Severe-cDC_10|Severe / Compartment, Disease Groups and Clusters

LYST NRP2 ST3GAL5 PLCL1 TMEM39A MMD

3.98e-05199140654bdadd04abaf8caa948b0177c037bc089ca07e6
ToppCellTransverse-Macrophage-LYVE1_Macrophage|Transverse / Region, Cell class and subclass

ACP3 STAC3 LILRA6 NRP2 MSX2 LRP3

3.98e-051991406facf79c256db5ae57bdb613e86ec90616a6f67ca
ToppCellTransverse-(6)_Macrophage-(61)_LYVE1_Macrophage|Transverse / shred on region, Cell_type, and subtype

ACP3 STAC3 LILRA6 NRP2 MSX2 LRP3

3.98e-051991406dcc2a7f4d1fa30aaaad655dd59c5a2b039d264bf
ToppCellTracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations

CPED1 SVEP1 BMP4 CORIN PLCL1 FLRT2

4.10e-05200140658b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Pltp|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 CDH20 NR2E1 PLCL1 CPNE7

4.54e-05124140536dfc702a570e1a1a6dde09f38badf9023ea7287
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp6_Car10|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 CDH20 NR2E1 CORIN CPNE7

4.90e-05126140561e599678680e5aa86291c2b347b2995014591ea
ToppCellHippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_2-Pvrl3|Hippocampus / BrainAtlas - Mouse McCarroll V32

KLK10 ACP3 FCGBP MUC2 MMD

5.09e-0512714059bc55cb9f4bddb274930784d12a83b9dceb35cb7
ToppCellBrain_organoid-organoid_Kanton_Nature-Organoid-2M-Stem_cells-neuroepithelial-like_cells|Organoid-2M / Sample Type, Dataset, Time_group, and Cell type.

TMPRSS6 SH2D3C NFATC1 WFIKKN1 PLCL1

5.09e-0512714059071cd0953c8bb6746dc9cd13d153e3d6ef40b08
ToppCellCOVID-19-kidney-Mito-rich_Int|kidney / Disease (COVID-19 only), tissue and cell type

CSMD3 SVEP1 EYS CSMD1 FBN3

5.48e-05129140557b705106aec7bbfc587de1ccd4f2335fc44dd6f
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPRSS6 SVEP1 HOXB1 WFIKKN1 CPNE7

5.69e-051301405e5acaa9aaa22b10d11410e2c01647b31354c21ed
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Igfbp4_Mab21l1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 CSMD3 CDH20 NR2E1 CPNE7

7.05e-0513614059cf076597e6fd9390850fda259daa13022f15893
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 NTMT2 CDH20 NR2E1 CPNE7

7.30e-051371405d346086f42d8f04d3fa67fe696834284acdc7080
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPRSS6 SVEP1 HOXB1 WFIKKN1 CPNE7

7.55e-051381405e2659949944bdf39b23c7275e380a7a937e2726c
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPRSS6 SVEP1 HOXB1 WFIKKN1 CPNE7

7.55e-051381405d5342383c5e52b92c39d7afe76560501be3ea5cd
ToppCellTCGA-Bile_Duct|World / Sample_Type by Project: Shred V9

CYP2C19 CYP2C9 TMPRSS6 NPC1L1 C8B

8.08e-051401405ca8a0ccbc2f501b759864fe9bb06dc8b44b6b31f
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

ITGA6 CSMD3 FBN3 CPNE7 DNAH11

9.85e-051461405ec1f793409d1a81c0f9323eb3c82ffe01dae0e44
ToppCellCOVID-19-kidney-Technical/muscle_(PCT)|kidney / Disease (COVID-19 only), tissue and cell type

CSMD2 CSMD3 EYS CTNND2 CSMD1

9.85e-051461405c55f1bdb6ac43b4118cb27ea7c879527e1afcbab
ToppCellrenal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

HYAL4 ITGA6 NDUFA7 CDH20 C18orf63

1.08e-041491405cc911b454fe4e4b489885b9920baa7eb01a027ba
ToppCellfacs-MAT-Fat-24m-Lymphocytic-NK_cell|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ACP3 NEK3 GUCD1 MMD MYBL1

1.19e-041521405fa03262e2853b7d35ef8cdbb652930abad90563c
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 CNTN6 CDH20 NR2E1 CPNE7

1.23e-0415314059c6fce56300ba5053efda59a438d63a808c497c0
ToppCellPND07-Endothelial-Endothelial_lymphatic|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 FLRT2 DUOXA2

1.56e-041611405133b4fadb499e842c19f573f9cf09ce08c1d4813
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 FLRT2 DUOXA2

1.56e-0416114059466b8658244116f8d21f2f88fb8c2d184b1bdf2
ToppCellPND07-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 FLRT2 DUOXA2

1.56e-041611405cb177ca10d848d0e25399ab5ebfcde1071fb94c2
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Gpc3_Slc18a3|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 NRP2 CDH20 NR2E1 CPNE7

1.65e-041631405ec9a20cfe0d69430f9c68cddd1ab0e4a3e4554b8
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 MSMP NRP2 HOXD8 CPNE7

1.70e-0416414054cfc9f92e49f86d3639e018b35b6a60dc62f494a
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 MSMP NRP2 HOXD8 CPNE7

1.70e-0416414057a8e5ef52a8fd2877d59ef0696af8a7af90bbed6
ToppCellPND10-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 MSMP NRP2 HOXD8 CPNE7

1.70e-0416414055e5bd81414ea2d64f73cdef19a0a78c17bec8c18
ToppCellPND10-Endothelial-Endothelial_lymphatic|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 MSMP NRP2 HOXD8 CPNE7

1.70e-041641405f13b8d9b7f42193f333d9a77571a1dde6bbb48d8
ToppCelldroplet-Fat-Scat-21m|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPRSS6 FCGBP STMN3 PAX1 DUOXA2

1.75e-0416514053f0c2486ea357d10dad0b703cf75cc29bdd5b5cf
ToppCellPND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 FLRT2 CPNE7

1.75e-041651405347b59aa625a8a960828b8620824d8ac48990e07
ToppCellPND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 FLRT2 CPNE7

1.75e-041651405507c89ece0a336b8e9c65b79889a714e17ddca27
ToppCellPND03-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 FLRT2 CPNE7

1.75e-04165140539a25be081a5d59c7cf107a997d352793d5025fb
ToppCellPND03-Endothelial-Endothelial_lymphatic|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 FLRT2 CPNE7

1.75e-0416514051890f9c33b0c5b381d57f97042da2610a093a6de
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip-Vip_Arhgap36_Hmcn1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CSMD3 CNTN6 CDH20 NR2E1 CPNE7

1.85e-0416714051c1b4722c6c0eff85a9b32ca7b4e281caebf63b0
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RC3H2 LILRA6 NEK3 ARID1B ARIH1

1.85e-041671405528493896aebe7d03d4b6ad2341b12927859e2e4
ToppCellfacs-Marrow-Granulocytes-18m-Lymphocytic-naive_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

RC3H2 LILRA6 NEK3 ARID1B ARIH1

1.85e-041671405a82e85caf79395baa48380786d9df32a86dfd1ce
ToppCellnormal_Lung-T/NK_cells-Exhausted_CD8+_T|T/NK_cells / Location, Cell class and cell subclass

A1BG CPNE2 NAALADL2 LYST CPNE7

1.90e-04168140576b49463895cdef27c90f831c6246bcb92b9761b
ToppCell3'_v3-bone_marrow-Myeloid_Mac-Intermediate_macrophages|bone_marrow / Manually curated celltypes from each tissue

STAC3 NRP2 CYFIP1 FLRT2 TNS1

1.90e-0416814058ade4d098aeecda2d80c1cad1cebe9a063eae948
ToppCellPND01-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 SH2D3C NRP2 HOXD8 NFATC1

1.95e-041691405f077e39e41fffe7672541f5b72b80faaf56c597c
ToppCellControl-Lymphocyte-T_NK-MAIT|Control / Disease, Lineage and Cell Type

CPNE2 COLQ ALOX12B MYBL1 CPNE7

1.95e-0416914058c2aac193a9c500f01a99a2ee530839c851b6222
ToppCell3'-Child09-12-SmallIntestine-Epithelial-Tuft-related-Tuft|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract

TMPRSS6 CNTN6 CSMD1 ALOX12B FBN3

1.95e-04169140505e12524d68d409fed386ffad233305683b4575b
ToppCellPND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC-LEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 NFATC1 DUOXA2

2.06e-041711405686f95892c3909973c66c9a27159a070a068f175
ToppCellPND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC-LEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 NFATC1 DUOXA2

2.06e-041711405f7ba03e7bdb687f93782c936c7b3374cc5b3b77c
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CPNE2 SEZ6L2 SVEP1 CNTN6 NR2E1

2.06e-041711405a5634b76476b8b2488a706bbab5141f7bd94631f
ToppCellfrontal_cortex-Neuronal-GABAergic_neuron-Vip|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 CSMD3 CDH20 NR2E1 CPNE7

2.06e-0417114055efd15300f865ebf651e0888265cbd717bc3b9d3
ToppCellPND14-Endothelial-Endothelial_lymphatic|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 NFATC1 DUOXA2

2.06e-041711405d0ac50071a3854d02113c455fcc940a6ec59bbb9
ToppCellPND14-Endothelial-Endothelial_lymphatic-Lymphatic_EC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

CPNE2 NRP2 HOXD8 NFATC1 DUOXA2

2.06e-041711405fbf8e9db00573adcada4b25730e191417b7c9999
ToppCellControl-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_3|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

SPEG CSMD2 CPED1 PLCL1 CSMD1

2.06e-0417114054ede831aed364cb5271f49a8b09bb6d0452f9b35
ToppCellrenal_medulla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

KIF24 SVEP1 BMP4 RNPEP CYP4X1

2.06e-0417114052a34685f7d83d1cf9a88d304173cbca868c5f9fd
ToppCellCOVID-19-Heart-T_cell|COVID-19 / Disease (COVID-19 only), tissue and cell type

CSMD3 ADCY2 EYS CSMD1 MYBL1

2.06e-041711405b2e753e811a7639956994609f73efcdb62d04f82
ToppCellMultiple_Sclerosis-Lymphocyte-T_NK-MAIT|Multiple_Sclerosis / Disease, Lineage and Cell Type

CPNE2 COLQ CTNND2 MYBL1 CPNE7

2.12e-04172140518bda0038cb37da6784e7bf7291272c108cfd9c5
ToppCellprimary_visual_cortex-Neuronal-GABAergic_neuron-Vip|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype

CPNE2 CSMD3 CDH20 NR2E1 CPNE7

2.12e-0417214057e1a7700a4c2b1d100da1d6e475e73498ebb605a
ToppCellfacs-Large_Intestine-Proximal-3m-Epithelial|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGEF5 TMPRSS6 GUCD1 ST3GAL5 MMD

2.18e-041731405e1378201b15ffb98e196ac39fe3ee4b4078953bd
ToppCellfacs-Large_Intestine-Proximal-3m|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

ARHGEF5 TMPRSS6 GUCD1 ST3GAL5 MMD

2.18e-04173140599532bb768ee35fed939a377acb5215d3f8904bd
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Mesenchymal|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP2 TMPRSS6 CUBN CSMD3 OTOGL

2.18e-04173140566f37c1437705734b20601656fa4aa1d92ca30be
ToppCellfacs-Diaphragm-Limb_Muscle-24m-Mesenchymal-nan|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

HIVEP2 TMPRSS6 CUBN CSMD3 OTOGL

2.18e-041731405649b08a409095592cccf31883be69c754411280d
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L2-6_VIP_VIP|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CPNE2 SVEP1 CNTN6 NR2E1 FBN3

2.29e-041751405e78bf0c33a741bb97e987e41ac33da9e623a08ec
ToppCelldroplet-Liver-Npc-21m-Lymphocytic|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation

A1BG MSX2 FCGBP CPNE7 DUOXA2

2.29e-041751405046e841811b22c39f80a9752f3223c1906de6f20
ToppCellLPS-antiTNF-Lymphocytic_NKT-T_cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ABCG1 NFATC1 LPXN PLCL1 MMD

2.36e-041761405ea27e18407b8a13e8212830da859efeb8f158690
ToppCellLPS-antiTNF-Lymphocytic_NKT-T_cells-T-cells|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

ABCG1 NFATC1 LPXN PLCL1 MMD

2.36e-041761405bfbab3c5b738b3b0b1540f2059d0245fbd8c0031
ToppCellHealthy-RBC|World / disease group, cell group and cell class

CPED1 CDH20 WFIKKN1 EML1 TNS1

2.42e-0417714052ce41e37fa7139c7bd2b464bd86c5601dc501515
ToppCell3'-Adult-LargeIntestine-Endothelial-lymphatic_endothelial-LEC1_(ACKR4+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

SH2D3C MSMP NRP2 ABCG1 HOXD8

2.42e-041771405dfaed388926ce050730492a532824af68bf4feff
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2-Inh_L1-3_VIP_GGH|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CPNE2 SVEP1 CNTN6 NR2E1 FBN3

2.42e-041771405d7976eac7e27044f6a859cc0c3398d08576e8c01
ToppCellkidney_cells-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic-Mast_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

EFCAB6 CCDC18 NRP2 MSX2 DNAH11

2.42e-04177140586c41d262142eeaa95ea7fa6668169eb1bb2953f
ToppCellHealthy-RBC|Healthy / disease group, cell group and cell class

CPED1 CDH20 WFIKKN1 EML1 TNS1

2.42e-041771405945d72ab52efa9a9468daace9f9ec676a891d963
ToppCellPrimary_Visual_cortex_(V1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_2|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CPNE2 SVEP1 CNTN6 NR2E1 FBN3

2.48e-0417814053c973aac16988e88f5677d3d695dd772ccfd6570
ToppCelldroplet-Fat-Scat-21m-Hematologic|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPRSS6 CCDC18 HOXB1 MOS

2.49e-04971404440d45ecfc9b66cb61d734118601e745892d51e3
ToppCelldroplet-Fat-Scat-21m-Hematologic-erythroblast|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMPRSS6 CCDC18 HOXB1 MOS

2.49e-049714046fff45d4c4bbd81a67e1ad12b131cfe6a5ab37e6
DrugDiethylcarbamazine citrate [1642-54-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

RC3H2 HIVEP2 MNX1 MAPKAPK2 LYST WDR74 ABCG1 ST3GAL5 SLF2

2.88e-0619813595485_DN
DrugTMBA

LYST RNPEP MMD

4.02e-0661353CID000145677
DiseaseS-6-hydroxywarfarin to S-warfarin ratio measurement

CPNE2 DLGAP1 CYP2C19 CYP2C9 CSMD3

5.01e-05881335EFO_0803332
DiseaseX-21258 measurement

CYP2C19 CYP2C9

6.03e-0531332EFO_0800802
Diseasewhole-brain volume

CUBN DNAH11

2.00e-0451332EFO_0005089
Diseasecerebellum cortex volume change measurement, age at assessment

HIVEP2 ABCG1 CSMD1

2.16e-04261333EFO_0008007, EFO_0021497
DiseaseThyroid Dyshormonogenesis 1

TG DUOXA2

2.99e-0461332C1848805
Diseaseeating disorder

SH2D3C ABCG1 CSMD1

4.04e-04321333EFO_0005203
Diseaseatrioventricular septal defect (implicated_via_orthology)

BMP4 DNAH11

4.17e-0471332DOID:0050651 (implicated_via_orthology)
DiseasePolycystic Kidney, Type 1 Autosomal Dominant Disease

BRD4 PRKCSH

5.55e-0481332C0887850
DiseaseWNT1-inducible-signaling pathway protein 1 measurement

TG C8B

8.86e-04101332EFO_0008321
Diseasecognitive impairment measurement

CNTN6 CSMD1 FBN3

1.04e-03441333EFO_0007998
DiseaseX-11308 measurement

CYP2C19 CYP2C9

1.08e-03111332EFO_0800693
DiseaseGM3 ganglioside measurement

CTNND2 FBN3

1.08e-03111332EFO_0021451
DiseaseCognitive impairment

NAALADL2 DMXL1

1.08e-03111332HP_0100543
Diseasecolon cancer (implicated_via_orthology)

NANOGP8 NANOG

1.08e-03111332DOID:219 (implicated_via_orthology)
DiseaseBarrett's esophagus (is_marker_for)

BMP4 MUC2

1.08e-03111332DOID:9206 (is_marker_for)
Diseasethymol sulfate measurement

CYP2C19 CYP2C9

1.29e-03121332EFO_0021170
Diseasecannabis dependence measurement

PAX1 CTNND2 CSMD1

1.34e-03481333EFO_0008457
Diseasejuvenile polyposis syndrome (implicated_via_orthology)

HIVEP2 BMP4

1.52e-03131332DOID:0050787 (implicated_via_orthology)
DiseaseCakut

BMP4 VPS33B

1.52e-03131332C1968949
DiseaseCongenital Hypothyroidism

POU1F1 TG

1.52e-03131332C0010308
Diseasetriacylglycerol 52:1 measurement

NFATC1 CSMD1

1.77e-03141332EFO_0010413
DiseaseHepatomegaly

A1BG STAC3 CRYGD

1.88e-03541333C0019209
DiseaseNon-steroidal anti-inflammatory and antirheumatic product use measurement

NDST1 TRIM26

2.04e-03151332EFO_0009935
DiseasePeroxisome biogenesis disorders

PEX7 PEX12

2.04e-03151332C1832200
Diseaselate-onset Alzheimers disease

NAALADL2 TAS2R5 ADAMTS20 ADAM17 PLCL1 CTNND2

2.14e-032921336EFO_1001870
Diseasemood instability measurement

HIVEP2 EYS PLCL1 CSMD1

2.73e-031281334EFO_0008475
Diseaseischemia (biomarker_via_orthology)

ARID1B MUC2

2.94e-03181332DOID:326 (biomarker_via_orthology)
Diseaseanorectal malformation

UROC1 CSMD2

3.28e-03191332MONDO_0019938
DiseaseMalignant neoplasm of breast

KLK10 TMPRSS6 CUBN TRAPPC8 CNTN6 BMP4 ARID1B CDH20 OTOGL ACCS TMEM39A TNS1

3.45e-03107413312C0006142
Diseaseschizophrenia (implicated_via_orthology)

HIVEP2 CSMD3 CSMD1

3.62e-03681333DOID:5419 (implicated_via_orthology)
Diseasetriacylglycerol 46:1 measurement

NFATC1 CSMD1

3.63e-03201332EFO_0010401
DiseaseFEV/FEC ratio

HIVEP2 SPEG ADCY2 NRP2 TG FCF1 HOXB1 BMP4 FCGBP NFATC1 PLCL1 CSMD1 TNS1

3.72e-03122813313EFO_0004713
Diseasevisceral:subcutaneous adipose tissue ratio

TMEM38B CNTN6 ADAM17

3.93e-03701333EFO_0004767
Diseaseinsomnia measurement

RC3H2 IFT57 CSMD3 HOXB1 PLCL1 CTNND2 DNAH11

4.04e-034431337EFO_0007876
Diseasesevere acute respiratory syndrome, COVID-19

DLGAP1 LYST CNTN6 TG EYS PXN CSMD1

4.24e-034471337EFO_0000694, MONDO_0100096

Protein segments in the cluster

PeptideGeneStartEntry
YRHAPPCLANFYIFS

LINC00596

91

Q86U02
QAYSACLPHIRFYGP

CPNE2

396

Q96FN4
EPVSFYTQPFSHYGQ

RNPEP

106

Q9H4A4
SPGYPAPYDNNLHCT

CSMD1

1291

Q96PZ7
SPNYPEDYGNHLHCV

CSMD2

591

Q7Z408
PNYPKNYSVGHNCVY

CSMD3

1776

Q7Z407
DLPSHGYTLIYTCQP

CSMD3

3426

Q7Z407
HLYEQAGPSFASYPL

CPED1

621

A4D0V7
PYLRDLGLNCPTYHN

ABCG1

306

P45844
PTPYYGAITQHVCLY

ACCS

191

Q96QU6
FSNCYKYNPPDHEVV

BRD4

426

O60885
NSGQTRYYSPCEEHP

ARHGEF5

176

Q12774
NSGQTRYYSPCEEHP

ARHGEF35

176

A5YM69
SYQINEHYPCITPCF

CCNJ

356

Q5T5M9
RHYAPLGFNAENPYT

DNAH11

1266

Q96DT5
PADHPYYTQRNSFQA

DLGAP1

41

O14490
EGYPNSQCNHYPGYS

ARID1B

371

Q8NFD5
IPGTYHCRCYPGFQA

FBN3

466

Q75N90
IVAPPGYQAFYCHGD

BMP4

326

P12644
YSPTYFGPEHAQVLS

DMXL1

1476

Q9Y485
KPEGSFQYPASYHSN

CTNND2

161

Q9UQB3
PIYTPNGGINYTDCH

FLRT2

626

O43155
GNLYNPDVHYSFNIP

ADAMTS20

826

P59510
YNSLDGYYSVACQPP

RC3H2

736

Q9HBD1
TFPVHQPGNYSCSYR

A1BG

171

P04217
LNYPNSYFTGLECGH

ARIH1

191

Q9Y4X5
IYGSYRNFVGPPHFQ

CYFIP1

901

Q7L576
PFYPVDYTADQHGTC

COLQ

361

Q9Y215
LLCGYPPFYSNHGLA

MAPKAPK2

256

P49137
LCPPLYTGQFCHQRY

EYS

836

Q5T1H1
AINPTYYDCHFAPEV

HOXD8

26

P13378
HCTNTGYKPLYIPSN

PRKCSH

76

P14314
ALSYSYPQVQGAHPA

MNX1

181

P50219
APFHNVNCPRGFLYF

CPSF1

976

Q10570
HLYPAFAQPGQECYL

MGAT5B

741

Q3V5L5
FAQCHALVPPQHYYD

MUC2

4701

Q02817
ALVPPQHYYDACVFD

MUC2

4706

Q02817
CVHGNAEYQPGSPVY

MUC2

4926

Q02817
PYLPGRLACATAQHY

PEX7

26

O00628
GFCDQYLAVPQHPYQ

NFATC1

381

O95644
TSPGYPQDYPSHQNC

NRP2

41

O60462
APTYPSLYSSYHQGC

NANOG

171

Q9H9S0
CGLFTHTIFYNEYPG

NDST1

486

P52848
SGYNYGIPHSCIRQN

KIF24

196

Q5T7B8
SPNYHRCSLLNPGYK

LMLN2

131

A0A1B0GTW7
HGFNATYQVKGYCLP

LRP3

356

O75074
LAYCPNDYHQLFSPR

LPXN

196

O60711
CYGSYSSNPHLLSFP

LILRA6

396

Q6PI73
CFEYTANPAGYNPSI

ITGA6

541

P23229
GPHIFQTCPSANYFD

PSMA1

141

P25786
FSTHPYLSYPRCLAQ

OR13H1

86

Q8NG92
LHQQYPGDIGCFAIY

MPI

241

P34949
QGCISPLPSHYSYEL

NEK3

216

P51956
PANGRYKPTCYEHAA

MMD

16

Q15546
GQPYCEKDYHNLFSP

PXN

401

P49023
LPVGPSHKLSNNYYC

NDUFA7

41

O95182
SEPYTTIHQPGYCAF

NPC1L1

21

Q9UHC9
DVYNGLLPPYASCHL

ACP3

301

P15309
GPYPYHICIIHEFSN

FBXO38

1021

Q6PIJ6
PACAYPASNQHGVYS

PAX1

366

P15863
HLVGRYCGNSFPLNY

CUBN

1806

O60494
FTPSSPCGLYHQYHL

DUOXA2

161

Q1HG44
ATGCIFYNNPAYADP

GUCD1

196

Q96NT3
YYCVSGLPISLPNHA

ADCY2

341

Q08462
HYECSSDHPNLQPYL

CRYGD

16

P07320
EYPLCNRGPSAYSAH

HOXB1

11

P14653
RHYFALPTNPGEQFY

IFT57

71

Q9NWB7
CNNFPTIIDYFPGTH

CYP2C19

216

P33261
YSPAVHRPCAEDYFN

EFCAB6

916

Q5THR3
SHPGLLNYSPYENVC

CCDC18

71

Q5T9S5
HPSCLFFQYNTQLGP

FCF1

51

Q9Y324
CVHQGTYHPPGQTFY

FCGBP

1191

Q9Y6R7
DDPRNGQHFYYSLAP

CDH20

521

Q9HBT6
PRNSCSLHYINPYQP

CPNE7

396

Q9UBL6
SDQRHPYAYLPFSAG

CYP4X1

436

Q8N118
NHLADNCYSNYPFPL

GCM1

306

Q9NP62
PDCHNYNVYAPNYSG

HYAL4

221

Q2M3T9
VILNCAANGYPSPHY

CNTN6

46

Q9UQ52
LPYNSTSYPNYFGHR

CORIN

466

Q9Y5Q5
PPTNTYVCHNPTNFY

LYST

2021

Q99698
YVQICAPNGRIYHFP

ALOX12B

86

O75342
YESTHNTPLNPCEYG

MARF1

1441

Q9Y4F3
APQCVFGYTTNPGYQ

GPR63

226

Q9BZJ6
YPASSCGFSYPSNQV

KRTAP13-1

21

Q8IUC0
YHPTSVYLPGCLNQS

KRTAP9-7

116

A8MTY7
FSYPCSQFRAPSHIY

EML1

766

O00423
YYHANAAVNDQSPGP

EMC9

81

Q9Y3B6
CNNFSPIIDYFPGTH

CYP2C9

216

P11712
SFVRLYQYPNFAGPH

EIF2A

196

Q9BY44
YQYPNFAGPHAALAN

EIF2A

201

Q9BY44
YAYLLQPSQFHGEPC

C8B

86

P07358
AIPAACPFHSYGDFQ

C18orf63

216

Q68DL7
PGYQYVSPEGNCIEH

MYBL1

231

P10243
TPTYYLQIEPQDGCH

CNST

6

Q6PJW8
YHFLSYNSAECLHPP

CPHXL

241

A0A1W2PPM1
NSYIHTRYPTQPCRF

NR2E1

326

Q9Y466
FAPCHIYISPGLYYQ

OTOGL

686

Q3ZCN5
ALCTPGYNARAPLHY

HGH1

161

Q9BTY7
CFQTPSYPLGGTYTH

MOS

231

P00540
HYGCASFIYLRPQSN

OR10K2

251

Q6IF99
VYSLPFCGPNVIYHF

OR4A8

161

P0C604
QAASIYGASYPFHRP

MSX2

231

P35548
TPLYAAHFRPGQYVD

MRPL3

191

P09001
VESYHCYSLQEFTPP

NTMT2

166

Q5VVY1
FYCHPYFQRDSPHLL

HSFX1

191

Q9UBD0
YRSVSEPPGYQAHSC

SPATA2L

346

Q8IUW3
LHYSVPSCHYGNQPS

POU1F1

51

P28069
VSQGYNFQLPGSYPH

SEC24A

46

O95486
APTYPSLYSSYHQGC

NANOGP8

171

Q6NSW7
HPDICLFPSNYVYNR

SETX

2261

Q7Z333
FGYDLNQPRTPLHYF

ST3GAL5

361

Q9UNP4
IHYQAYLLSCGFPPR

SEZ6L2

281

Q6UXD5
ISHCYPEYLSNFPQE

SDAD1

66

Q9NVU7
GFLTSAYHYVQCPVP

SLF2

791

Q8IX21
FYQECGGHYLNLPLS

SERTAD4

191

Q9NUC0
HYVRSHQACPITGYP

PEX12

331

O00623
IQYQCFPGYKLHGNS

SVEP1

2971

Q4LDE5
ICSCFYTQPHPNTVY

STMN3

21

Q9NZ72
PRANSHGGVCPKAYY

ADAM17

356

P78536
TPPRFAQHGTFEYEY

SFPQ

476

P23246
LTFYHPPQGNSSIRY

TAS2R5

146

Q9NYW4
QYTIPFECLQPGYRH

PLCL1

811

Q15111
CTGYHQVRVYDPASP

WDR74

201

Q6RFH5
HPGVYSKCYFQAQAP

MSMP

31

Q1L6U9
SGIPDCYYNVTHLPV

SPEG

2726

Q15772
CHNPFNGGYYPVQLS

UROC1

346

Q96N76
PYQPASGLCYVQNHF

RHBDD2

296

Q6NTF9
YPYNHPASCTSLNFH

TMEM39A

101

Q9NV64
YPFGVYVPLCCFHQD

TMEM39A

191

Q9NV64
QNYRPHPQRFTYCSQ

TRIM25

486

Q14258
SLDAPHSTYNLYCPF

STXBP2

146

Q15833
YDYQPCLAGPNQDFH

TNS1

796

Q9HBL0
CPHDLVSQGYSYLPV

TMEM38B

96

Q9NVV0
YKSAYLHPQQFDCEP

TRIM26

341

Q12899
VNHSYCSVPGYYPSN

PIAS4

216

Q8N2W9
AYSPLLQQCHPFVYG

WFIKKN1

376

Q96NZ8
IPSNFHPTQYCLNSY

TRAPPC8

726

Q9Y2L5
SYSDPDSGHYCQLQP

SH2D3C

486

Q8N5H7
EQTYPCYSGASGLHP

HIVEP2

1276

P31629
PGFHRAYSSPLYSNQ

STAC3

146

Q96MF2
HFIRSGNPNYPYEFS

TG

2661

P01266
HLLSTLYGPFPNCYG

VPS33B

181

Q9H267
RVHYGLYNQSDPCPG

TMPRSS6

446

Q8IU80
AAASAYYNPGNPHNV

WBP2

226

Q969T9
GVYPCGSAQHPAVYT

KLK10

246

O43240
LIGYYVHTNCPSDAP

NAALADL2

141

Q58DX5